Rocket Pharmaceuticals, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:RCKT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -55.79 M-48.96 M-50.42 M-34.84 M-45.39 M -179.62 M Cash from investing activities -58.03 M31.76 M93.62 M36.42 M17.45 M 179.25 M Cash from financing activities 0215 K-67 K0-1 000 147 K Free cash flow -55.79 M-48.96 M-50.42 M-34.84 M-45.39 M -179.62 M

News

Regenxbio: 'Strong Buy' On FDA Course Reversal For NAVSUNLI And Potential AA DMD Filing

RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease

Rocket Pharmaceuticals: Kresladi Validates Platform, Commercial Upside Limited (RCKT)

Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 Transcript

Rocket Pharmaceuticals enters $100 million at-the-market offering agreement

Avago, Lumentum among market cap stock movers on Monday

Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program

Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Alpha Technology Group (NASDAQ:ATGL), Fulcrum Therapeutics (NASDAQ:FULC)